- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Pacific Biosciences insider sells $18,870 in shares
Christian Henry, a Pacific Biosciences insider, sold 12,497 shares of the company's stock.
Mar. 5, 2026 at 6:22pm
Got story updates? Submit your updates here. ›
Pacific Biosciences of California, Inc. (NASDAQ:PACB) insider Christian Henry sold 12,497 shares of the company's stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $1.51, for a total value of $18,870.47. Following the sale, Henry now owns 3,581,813 shares in the company, valued at $5,408,537.63.
Why it matters
Insider transactions, such as stock sales by company insiders, can provide insights into management's views on the company's prospects. While a single insider sale does not necessarily indicate negative sentiment, tracking insider activity can help investors understand how insiders perceive the company's valuation and future performance.
The details
The sale represented a 0.35% decrease in Henry's position. Pacific Biosciences of California, Inc. is a biotechnology company that develops and sells high-performance DNA sequencing systems. The company's shares traded down $0.05 on Thursday, reaching $1.51.
- The transaction occurred on Tuesday, March 3rd.
The players
Christian Henry
An insider at Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc.
A biotechnology company that develops and sells high-performance DNA sequencing systems.
The takeaway
This insider sale by Christian Henry, a Pacific Biosciences insider, provides a data point about management's perspective on the company's valuation, though a single transaction does not necessarily indicate broader sentiment. Investors may want to monitor further insider activity and the company's financial performance to gain a more complete understanding of the factors driving the stock price.

